Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

shareholders$
28.0$
94.8$
97.3$
260.9Plus:Interest expense54.612.7116.781.8Interest income(1.2)(0.5)(2.5)(2.1)Provision for income taxes88.261.5146.8196.9Depreciation (includes accelerated depreciation)36.821.397.593.6Amortization(1)148.4151.5481.9355.5EBITDA354.8341.3937.7986.6Adjusted for:Global supply chain initiative8.40.214.411.0Acquisition and licensing charges77.814.9294.137.7Non-cash impairment charges29.918.7149.544.3Non-recurring (gains) losses(119.3)(0.9)(134.6)(13.2)Legal settlements27.35.087.75.0Accretion (income) expense-(0.1)0.4(0.3)Share-based compensation14.114.348.739.8Adjusted EBITDA$
393.0$
393.4$
,397.9$
,110.9(1) Includes amortization of excess purchase price on equity method investment.The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2013 to non-GAAP net income and non-GAAP earnings per diluted share:

 Table 6Actavis, Inc.Reconciliation Table - Forecasted Non-GAAP Earnings Per Diluted Share(Unaudited; in millions except per share amounts)Forecast for Twelve Months
Ending December 31, 2013LowHighGAAP to Non-GAAP net income calculationGAAP net income$
440$
490Adjusted for:Amortization 625630Global supply chain initiative3535Acquisition and licensing charges 150150Interest accretion on contingent liability 77Non-cash impairment charges Non-recurring (gains) losses Income taxes on items above(222)(224)Adjusted Non-GAAP net income1,0351,088Diluted earnings per shareDiluted earnings per share - GAAP $
3.27$
3.65Diluted earnings per share - Non-GAAP$
7.70$
8.10Diluted weighted average common shares outstanding*134.4134.4*Includes the maximum of 5.5 million shares potentially issuable to the former shareholders of the Actavis Group, subject to final determination of the legacy Actavis business' 2012 Cash EBITDA as calculated in the Actavis acquisit
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... VANCOUVER, British Columbia and ... DelMar Pharmaceuticals, Inc. (OTCQX: ... focused on developing and commercializing proven cancer therapies ... data at the American Association of Cancer ... on the potential for its lead product ...
(Date:5/29/2015)... 29, 2015 Educating the community continues ... for the Advancement of Wound Care (AAWC), which ... from AAWC,s corporate partners, the Association provides medical ... the AAWC website at http://aawconline.org/education-for-the-generalist/ . The ... with links to various CME/CEU educational programs. This ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of Jain PharmaBiotech,s new ...  to their offering.       ... or gene silencing involves the use of ... cell, this material is processed into short ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5The Association for the Advancement of Wound Care Educates the Public 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3
... Reportlinker.com announces that a new market ... Germany Surgical Equipment Market ... http://www.reportlinker.com/p0254518/Germany-Surgical-Equipment-Market-Outlook-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment Germany Surgical Equipment ... Summary GlobalData,s new report, ...
... OSLO, Norway, October 31, 2011 Oslo ... oncology. The true strength of the Norwegian cluster lies ... than the ones available to cancer patients today. ... cluster within the field of oncology, dedicated to accelerating ...
Cached Medicine Technology:Germany Surgical Equipment Market Outlook to 2016 2Germany Surgical Equipment Market Outlook to 2016 3Germany Surgical Equipment Market Outlook to 2016 4Germany Surgical Equipment Market Outlook to 2016 5Germany Surgical Equipment Market Outlook to 2016 6Germany Surgical Equipment Market Outlook to 2016 7Germany Surgical Equipment Market Outlook to 2016 8Germany Surgical Equipment Market Outlook to 2016 9Expanding Norwegian Cluster of Excellence Dedicated to Oncology 2Expanding Norwegian Cluster of Excellence Dedicated to Oncology 3
(Date:5/29/2015)... 2015 Dot Hill can mark one more item ... Lake Prince Woods retirement community is the oldest woman ... Virginia. , “It was great fun!”, she exclaimed. “I’ve always ... me to so they thought this would be ok.” , “We ... vertical wind tunnel,” she described. “I don’t remember it being ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 On May ... You Really be When You Get Botox ?” reported ... according to Google. Elle partnered with Google to determine these ... The most searched question in California, for example, is how ... the most common search query is what's the appropriate age ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Jan Wooden Howse ... in one thing above all else: God does no wrong. ... subject of her son’s passing is titled “God Does No ... is confronted with great personal tragedy. , “My story ... someone dear to you into something productive, something healing,” Howse ...
(Date:5/29/2015)... May 29, 2015 Johnson & ... a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement ... due to his use of the antipsychotic medication. ... selected for the third bellwether trial to involve ... litigation underway in Pennsylvania’s Philadelphia Court of Common ...
(Date:5/29/2015)... California (PRWEB) May 29, 2015 A group ... and have joined the national effort to teach this “new ... in the U.S. have been “sickened” by the recent implementation ... love it or hate it, Common Core is now a ... of Columbia. Parents are now seeking ways to improve ...
Breaking Medicine News(10 mins):Health News:Indoor Skydiving Brings Thrills to Seniors 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Turning grief from a child’s passing into virtue 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Doctors Discover a Cure for the Common Core 2
... , , TEWKSBURY, Mass., ... is; on eggnog, cookies, candy and holiday buffet fare even though we ... the same with our four-legged, furry companions. The advent of the New ... for our pets, according to the experts at Wellness® Natural Food ...
... analyzing the genetics of cancers from different parts of the ... That process is already gaining traction at the ... where researchers are one year into a three-year project to ... gene expressed by 1,000 tumors. Over the past ...
... cellulose produced by bacteria could be used for artificial blood ... of blood clots than the synthetic materials currently used for ... the University of Gothenburg, Sweden. Produced by a bacterium ... enough to cope with blood pressure and works well with ...
... more serious infections than previously realised, with more than 3,000 ... Academy at the University of Gothenburg, Sweden. To date ... this often deadly infection is, but previously it has been ... in Sweden. A population-based review of cases in the county ...
... inherited form of disease , TUESDAY, Dec. 22 (HealthDay News) ... therapy may offer lifetime protection against the progression of the ... in mice. , The most common form of emphysema in ... in the alpha-1 anti-trypsin gene, the authors of the study ...
... , , ... ) today announced that its lending arm, IBM Global Financing, has ... (EHR) providers, highlighting the growing need for private financing for health ... adopt health IT solutions. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO ) , ...
Cached Medicine News:Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 2Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 3Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 4Health News:Chicago Cancer Genome Project studies genetics of 1,000 tumors 2Health News:Chicago Cancer Genome Project studies genetics of 1,000 tumors 3Health News:Chicago Cancer Genome Project studies genetics of 1,000 tumors 4Health News:Gene Therapy Holds Promise for Emphysema 2Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 2Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 3Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 4Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 5
PremierEdge Stab Knives - 15....
More Info Lacrimal Intubation Set. Size: Probes 23g x 7"....
... versatile and uncomplicated use of the Leica ... obtained make it the instrument of choice ... cryostat applications. The open top stainless steel ... accessible and offers ample space for convenient ...
The HM 550 series is a uniquely progressive concept for use with frozen specimens of all types. User applications define module selection and make even serial sectioning enjoyable....
Medicine Products: